3.29
전일 마감가:
$3.16
열려 있는:
$3.2
하루 거래량:
307.64K
Relative Volume:
0.53
시가총액:
$182.06M
수익:
$163.78M
순이익/손실:
$25.88M
주가수익비율:
5.0615
EPS:
0.65
순현금흐름:
$-28.66M
1주 성능:
+0.61%
1개월 성능:
+11.90%
6개월 성능:
-40.51%
1년 성능:
-62.87%
Voyager Therapeutics Inc Stock (VYGR) Company Profile
명칭
Voyager Therapeutics Inc
전화
857-259-5340
주소
75 HAYDEN AVENUE, LEXINGTON, MA
VYGR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
VYGR
Voyager Therapeutics Inc
|
3.29 | 170.16M | 163.78M | 25.88M | -28.66M | 0.65 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
477.86 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
575.47 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
327.45 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
572.00 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.33 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-01-10 | 개시 | Cantor Fitzgerald | Overweight |
2024-12-02 | 개시 | Citigroup | Buy |
2024-11-29 | 재개 | Wedbush | Outperform |
2024-10-16 | 개시 | Leerink Partners | Outperform |
2024-03-26 | 개시 | Guggenheim | Buy |
2024-03-19 | 개시 | H.C. Wainwright | Buy |
2024-03-07 | 개시 | Citigroup | Buy |
2024-01-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2023-05-10 | 개시 | Truist | Buy |
2023-03-10 | 개시 | Oppenheimer | Outperform |
2021-10-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2021-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2021-02-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
2021-02-03 | 다운그레이드 | Wedbush | Outperform → Neutral |
2020-12-24 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
2020-12-23 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2020-11-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2020-11-10 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
2020-11-10 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2020-03-19 | 개시 | The Benchmark Company | Buy |
2020-02-06 | 개시 | Oppenheimer | Outperform |
2018-11-15 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2018-09-10 | 재개 | BTIG Research | Buy |
2018-09-10 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2018-06-04 | 개시 | H.C. Wainwright | Buy |
2018-03-12 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2018-03-12 | 다운그레이드 | Wedbush | Outperform → Neutral |
2018-02-02 | 개시 | Morgan Stanley | Overweight |
2017-11-28 | 재개 | Piper Jaffray | Overweight |
2017-10-31 | 개시 | Robert W. Baird | Outperform |
2017-10-27 | 개시 | Canaccord Genuity | Buy |
2017-10-23 | 재확인 | Stifel | Buy |
2017-10-12 | 개시 | Raymond James | Outperform |
2017-08-17 | 개시 | Evercore ISI | Outperform |
2017-07-28 | 재개 | Stifel | Buy |
모두보기
Voyager Therapeutics Inc 주식(VYGR)의 최신 뉴스
Is Voyager Therapeutics Inc. a good long term investmentHigh-yield trading alerts - Autocar Professional
Voyager Therapeutics Inc. Stock Analysis and ForecastExplosive market performance - jammulinksnews.com
What drives Voyager Therapeutics Inc. stock priceTriple-digit returns - jammulinksnews.com
Why Voyager Therapeutics Inc. stock attracts strong analyst attentionFree Smart Money Stock Analysis - Newser
Voyager Therapeutics’ Promising Alzheimer’s Study: A Potential Game-Changer? - MSN
Why did Voyager's net profit surge in Q4 2024 despite high operating expenses? - AInvest
What analysts say about Voyager Therapeutics Inc. stockMarket-crushing stock picks - Autocar Professional
Does Voyager Therapeutics Inc. stock pay reliable dividendsTrend Based Entry Alerts - beatles.ru
Voyager Therapeutics adds new gene therapy to Alzheimer’s program - BioWorld MedTech
Baird reiterates Outperform rating on Voyager Therapeutics stock with $18 price target - Investing.com Canada
Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease - GlobeNewswire
How Voyager Therapeutics Inc. stock performs during market volatilityDaily Top Gainers - Newser
Voyager Therapeutics Introduces New Program Targeting Genetic Risk Factor of Alzheimer's Disease - 富途牛牛
Voyager Therapeutics Launches New Gene Therapy Program Targeting APOE for Alzheimer's Disease Treatment - Quiver Quantitative
Voyager Therapeutics unveils APOE-targeting Alzheimer’s therapy program By Investing.com - Investing.com South Africa
Voyager Therapeutics unveils APOE-targeting Alzheimer’s therapy program - Investing.com
Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach - GlobeNewswire Inc.
What makes Voyager Therapeutics Inc. stock price move sharplyBreakout Setup Scanner - Newser
Allspring Global Investments Holdings LLC Buys 21,149 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Brokerages - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by Rhumbline Advisers - Defense World
Financial Comparison: Prime Medicine (NYSE:PRME) & Voyager Therapeutics (NASDAQ:VYGR) - Defense World
Voyager Therapeutics at H.C. Wainwright: Genetic Innovation in Focus By Investing.com - Investing.com Canada
Equities Analysts Offer Predictions for VYGR FY2026 Earnings - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspecti - GuruFocus
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference | VYGR Stock News - GuruFocus
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - GlobeNewswire
Millennium Management LLC Sells 60,935 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Squarepoint Ops LLC Decreases Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics: Navigating AAV Headwinds And A Long Road For VY7523 (Downgrade) - Seeking Alpha
Voyager Therapeutics Approves Stock Plans at Annual Meeting - TipRanks
BNP Paribas Financial Markets Sells 43,210 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Holdings Lowered by ProShare Advisors LLC - Defense World
Deutsche Bank AG Cuts Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews
Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Voyager Therapeutics Inc (VYGR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Voyager Therapeutics Inc 주식 (VYGR) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Sandrock Alfred | President and CEO |
Apr 02 '25 |
Sale |
3.43 |
10,885 |
37,336 |
430,931 |
자본화:
|
볼륨(24시간):